Citation Impact
Citing Papers
Senescent cells and macrophages: key players for regeneration?
2020
A Phase II Study of the Efficacy and Safety of the Combination Therapy of the MEK Inhibitor Refametinib (BAY 86-9766) Plus Sorafenib for Asian Patients with Unresectable Hepatocellular Carcinoma
2014
New frontiers in liver resection for hepatocellular carcinoma
2020
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Mechanisms of hepatic stellate cell activation
2017 Standout
Hepatic Stellate Cells and Liver Fibrosis
2013
The role of stem cells in liver repair and fibrosis
2009
Macrophages in immunoregulation and therapeutics
2023 Standout
Hepatocellular carcinoma
2021 Standout
Personalized treatment of patients with very early hepatocellular carcinoma
2016
Hepatocellular carcinoma
2022 Standout
Hepatocellular Carcinoma
2019 Standout
Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma
2020
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
2014
Works of Xiaoping Chen being referenced
Surgery for Intermediate and Advanced Hepatocellular Carcinoma: A Consensus Report from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014)
2016
Oval Cell Response Is Attenuated by Depletion of Liver Resident Macrophages in the 2-AAF/Partial Hepatectomy Rat
2012
Severity of cirrhosis should determine the operative modality for patients with early hepatocellular carcinoma and compensated liver function
2015
Hepatic non-parenchymal cells and extracellular matrix participate in oval cell-mediated liver regeneration
2009
Effect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma
2018
Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sor-treated patients (pts): Clinical findings in pts with liver dysfunction.
2013
HSCs play a distinct role in different phases of oval cell‐mediated liver regeneration
2012